# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-004718
Filing Date
2025-04-15
Accepted
2025-04-15 09:20:05
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 15295
2 |  | proxy_001.jpg | GRAPHIC | 476408
3 |  | proxy_002.jpg | GRAPHIC | 462542
| Complete submission text file | 0001641172-25-004718.txt |  | 1309854

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38286 | Film No.: 25837832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)